Showing results (31-40 of 61) with videos related to
Sort By:
Pageof 7
British Journal of Clinical Pharmacology|November 21, 2024
Risk factors for lenvatinib-induced hypertension in patients with hepatocellular carcinoma: A retrospective studyShusuke Uekusa, Misaki Nakashin, Yuki Hanai, et al.Experimental and Therapeutic Medicine|August 13, 2013
Arrival time parametric imaging of the hemodynamic balance changes between the hepatic artery and the portal vein during deep inspiration, using Sonazoid-enhanced ultrasonography: A case of Budd-Chiari syndromeNoritaka Wakui, Ryuji Takayama, Yasushi Matsukiyo, et al.Experimental and Therapeutic Medicine|February 14, 2013
Visualization of segmental arterialization with arrival time parametric imaging using Sonazoid-enhanced ultrasonography in portal vein thrombosis: A case reportNoritaka Wakui, Ryuji Takayama, Yasushi Matsukiyo, et al.Clinical Journal of Gastroenterology|April 17, 2022
Usefulness of partial splenic embolization for left-sided portal hypertension in a patient with a pancreatic neuroendocrine neoplasm: a case report and review of the literatureTeppei Matsui, Hidenari Nagai, Makoto Amanuma, et al.Hepato-Gastroenterology|June 30, 2010
Recurrence incidence of small HCC in cirrhosis patients by ablation versus injectionNoritaka Wakui, Kazunari Iida, Takashi Ikehara, et al.Clinical Cancer Drugs|September 6, 2016
The Importance of Lamivudine Therapy in Liver Cirrhosis Patients Related HBV with Advanced Hepatocellular Carcinoma Receiving Hepatic Arterial Infusion ChemotherapyKoichi Momiyama, Hidenari Nagai, Yu Ogino, et al.Clinical & Developmental Immunology|June 6, 2012
Sorafenib prevents escape from host immunity in liver cirrhosis patients with advanced hepatocellular carcinomaHidenari Nagai, Takanori Mukozu, Daigo Matsui, et al.Hepatology Research : the Official Journal of the Japan Society of Hepatology|November 19, 2005
Early immune-mediated response to ribavirin combined with IFN in patients with chronic hepatitis CKoji Ishii, Yasukiyo Sumino, Mie Shinohara, et al.Cancer Chemotherapy and Pharmacology|February 25, 2010
Hepatotoxicity of intra-arterial combination chemotherapy in patients with liver cirrhosis and advanced hepatocellular carcinomaHidenari Nagai, Teppei Matsui, Masahiro Kanayama, et al.Oncology Letters|June 7, 2013
A case of poorly differentiated hepatocellular carcinoma with intriguing ultrasonography findingsNoritaka Wakui, Ryuji Takayama, Yasushi Matsukiyo, et al.Pageof 7